Mitra Abbasifard

5.7k citations
42 papers · 386 indexed · h-index 11
Topics
Curcumin's Biomedical Applications (6 papers)COVID-19 Clinical Research Studies (5 papers)Systemic Lupus Erythematosus Research (5 papers)

In The Last Decade

Mitra Abbasifard

39 papers receiving 375 citations

Peers

Mitra Abbasifard
Comparison fields: 5 of 90
  • Molecular Biology 106
  • Molecular Medicine 103
  • Immunology 53
  • Infectious Diseases 42
  • Pharmacology 38
Replace Guijun Zhang with:
Guijun Zhang China
Lili Dong China
Samaneh Abdolmohammadi‐Vahid Iran
Juntao Yin China
Aporn Chuncharunee Thailand
Hamed Valizadeh Iran
Armin Sadeghi Iran
Kazunari Kanke Japan
Kui Yang China
Ahmed Shata Egypt
Mitra Abbasifard relative to Guijun Zhang China Guijun Zhang's profile →
Citations per field
00.5×2.7×
Guijun Zhang · 1×
Citations per year

Countries citing papers authored by Mitra Abbasifard

Since Specialization
Citations

This map shows the geographic impact of Mitra Abbasifard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitra Abbasifard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitra Abbasifard more than expected).

Fields of papers citing papers by Mitra Abbasifard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitra Abbasifard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitra Abbasifard. The network helps show where Mitra Abbasifard may publish in the future.

Co-authorship network of co-authors of Mitra Abbasifard

This figure shows the co-authorship network connecting the top 25 collaborators of Mitra Abbasifard. A scholar is included among the top collaborators of Mitra Abbasifard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitra Abbasifard. Mitra Abbasifard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 1
6 1
7 10
8 4
9 1
10 14
11 4
12 2
13 9
14 10
15 6
16 13
17 1
18 4
19 31
20 2

About Mitra Abbasifard

Mitra Abbasifard is a scholar working on Molecular Medicine, Rheumatology and Pharmacology, having authored 42 papers that have together received 386 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (6 papers), COVID-19 Clinical Research Studies (5 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Molecular Medicine (103 citations), Pharmaceutical Science (22 citations) and Pharmacology (25 citations). Mitra Abbasifard has collaborated with scholars based in Iran, Australia and United States. Frequent co-authors include Amirhossein Sahebkar, Muhammed Majeed, Tannaz Jamialahmadi, Maciej Banach, Paul C. Guest, Amir Vahedian‐Azimi, Asadollah Mohammadi, Farshid Rahimi‐Bashar, Gholamreza Bazmandegan and Maryam Moossavi. Their work appears in journals such as Scientific Reports, International Journal of Pharmaceutics and Nutrients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026